01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
We recently reported that on June 11, 2019, a three-judge panel of the U.S. Court of Appeals for the...
Read More >
In a win for franchisors, the Ninth Circuit recently affirmed the district court’s summary judgment...
Read More >
Bricker attorneys Frank Merrill and Christine Rideout Schirra will be presenting 'Environmental Perm...
Read More >
The offeror for Moss Bros sought to rely on standard material adverse change conditions to lapse the...
Read More >
The Illinois legislature unanimously enacted the Illinois Artificial Intelligence Video Interview Ac...
Read More >
Wednesday, January 8th, saw a state court conclude that California’s controversial new misclassific...
Read More >